Background and aims: Antiepileptic drugs (AEDs) do not effectively control seizures in newborn brain and there is growing concern that use of standard AEDs such as phenobarbital may exacerbate seizures and brain injury. Recent data suggests this may be due to the changing role of the GABA A receptor (an AED target) during normal neurodevelopment, a process tightly coupled to developmental expression of the chloride cotransporter proteins NKCC1 and KCC2. The timing of the 'switch' in GABA A receptor function from excitation to inhibition is unclear and in human may not be completed until 3-4 months of age. The aim of this project was to establish the developmental profile of NKCC1, KCC2 and the GABA A receptor α 1 and α 3 subunits in piglet brain.
